The time to embrace people-based marketing in pharma is now—but how? Now more than ever, pharma marketers have an opportunity to build personal and direct relationships at scale and can find opportunities to leverage people-based marketing (PBM) to reach both consumers (patients, caregivers) and healthcare providers (HCPs) on a deeper level, and drive measurable results.
Today we are pleased to announce the release of the Q2 2018 Digital Marketing Report for download. As always, the report includes key trends and analyses on the most important developments taking shape across Google, Facebook, Amazon, and more.
Over a four-part blog post series, I’ll explore each of these best practices to help pharma marketers revolutionize their current strategies to achieve marketing excellence. This first post focuses on the traditional approach to email, as many pharma marketers would like to move away from traditional email development.
The use of co-pay or coupon cards are typically considered for prescription drugs farther along in their life cycle, when there are either new entrants in the category or when generics of less-expensive biosimilar products become available. A logical thought in the latter case is “all else being equal, a patient and prescriber will prefer the branded product.”